Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients (Q74699926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

R Oinonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Franssila

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

L Teerenhovi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Lappalainen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E Elonen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

329-336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

1 reference

7 January 2021

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Patterns of survival in mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Guidelines for reporting outcomes of lymphoma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Mantle cell lymphoma: a therapeutic dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Mantle cell lymphoma: a clinicopathological study of 55 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Mantle-cell lymphoma: a population-based clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910056-9

7 January 2021

10.1016/S0959-8049(97)10056-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9640217%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference